{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T16:00:37Z","timestamp":1771862437632,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Natural Science Foundation of Fujian","award":["No.2024J08262"],"award-info":[{"award-number":["No.2024J08262"]}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["No.2022J011004"],"award-info":[{"award-number":["No.2022J011004"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fujian Provincial Joint Funding Project of Scientific and Technological InFujian Provincial Joint Funding Project of Scientific and Technological Innovationnovation","award":["No.2023Y9298"],"award-info":[{"award-number":["No.2023Y9298"]}]},{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"publisher","award":["No.2022CXB001"],"award-info":[{"award-number":["No.2022CXB001"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00228-025-03984-7","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T07:13:45Z","timestamp":1768806825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of anti-gout medications on eight cardiovascular diseases: a Mendelian randomized study"],"prefix":"10.1007","volume":"82","author":[{"given":"Pingping","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miaozhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"issue":"8","key":"3984_CR1","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","volume":"145","author":"CW Tsao","year":"2022","unstructured":"Tsao CW, Aday AW, Almarzooq ZI et al (2022) Heart disease and stroke Statistics-2022 update: A report from the American heart Association. Circulation 145(8):e153\u2013e639","journal-title":"Circulation"},{"issue":"10159","key":"3984_CR2","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","volume":"392","author":"regional Global","year":"2018","unstructured":"Global regional (2018) National age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet 392(10159):1736\u20131788","journal-title":"Lancet"},{"issue":"44","key":"3984_CR3","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1093\/eurheartj\/ehab797","volume":"42","author":"F Crea","year":"2021","unstructured":"Crea F (2021) How epidemiology can improve the Understanding of cardiovascular disease: from mechanisms to treatment. Eur Heart J 42(44):4503\u20134507","journal-title":"Eur Heart J"},{"key":"3984_CR4","doi-asserted-by":"crossref","unstructured":"Ain QU, Sarfraz M, Prasesti GK et al (2021) Confounders in identification and analysis of inflammatory biomarkers in cardiovascular diseases. Biomolecules 11(10):1464","DOI":"10.3390\/biom11101464"},{"key":"3984_CR5","doi-asserted-by":"crossref","unstructured":"Zhang H, Dhalla NS (2024) The role of Pro-Inflammatory cytokines in the pathogenesis of cardiovascular Disease. Int J Mol Sci 25(2):1082","DOI":"10.3390\/ijms25021082"},{"key":"3984_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijcard.2015.08.088","volume":"213","author":"M Volterrani","year":"2016","unstructured":"Volterrani M, Iellamo F, Sposato B et al (2016) Uric acid Lowering therapy in cardiovascular diseases. Int J Cardiol 213:20\u201322","journal-title":"Int J Cardiol"},{"issue":"1","key":"3984_CR7","doi-asserted-by":"publisher","first-page":"e000081","DOI":"10.1136\/bmjmed-2021-000081","volume":"1","author":"K Cai","year":"2022","unstructured":"Cai K, Wu B, Mehta S et al (2022) Association between gout and cardiovascular outcomes in adults with no history of cardiovascular disease: large data linkage study in new Zealand. BMJ Med 1(1):e000081","journal-title":"BMJ Med"},{"issue":"2","key":"3984_CR8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/BOR.0000000000000585","volume":"31","author":"AM Abeles","year":"2019","unstructured":"Abeles AM, Pillinger MH (2019) Gout and cardiovascular disease: crystallized confusion. Curr Opin Rheumatol 31(2):118\u2013124","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"3984_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1161\/CIRCULATIONAHA.121.056171","volume":"145","author":"SG Deftereos","year":"2022","unstructured":"Deftereos SG, Beerkens FJ, Shah B et al (2022) Colchicine in cardiovascular disease. In-Depth Review Circulation 145(1):61\u201378","journal-title":"In-Depth Review Circulation"},{"issue":"9","key":"3984_CR10","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41569-020-0366-z","volume":"17","author":"AM Schjerning","year":"2020","unstructured":"Schjerning AM, McGettigan P, Gislason G (2020) Cardiovascular effects and safety of (non-aspirin) NSAIDs. Nat Rev Cardiol 17(9):574\u2013584","journal-title":"Nat Rev Cardiol"},{"issue":"11","key":"3984_CR11","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1080\/17512433.2016.1230495","volume":"9","author":"G Zingler","year":"2016","unstructured":"Zingler G, Hermann B, Fischer T et al (2016) Cardiovascular adverse events by non-steroidal anti-inflammatory drugs: when the benefits outweigh the risks. Expert Rev Clin Pharmacol 9(11):1479\u20131492","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"6","key":"3984_CR12","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s00296-024-05584-7","volume":"44","author":"A Bech-Drewes","year":"2024","unstructured":"Bech-Drewes A, Bonnesen K, Hauge EM et al (2024) Cardiovascular safety of using non-steroidal anti-inflammatory drugs for gout: a Danish nationwide case-crossover study. Rheumatol Int 44(6):1061\u20131069","journal-title":"Rheumatol Int"},{"issue":"12","key":"3984_CR13","doi-asserted-by":"publisher","first-page":"e0260844","DOI":"10.1371\/journal.pone.0260844","volume":"16","author":"KH van der Pol","year":"2021","unstructured":"van der Pol KH, Wever KE, Verbakel M et al (2021) Allopurinol to reduce cardiovascular morbidity and mortality: A systematic review and meta-analysis. PLoS ONE 16(12):e0260844","journal-title":"PLoS ONE"},{"issue":"3","key":"3984_CR14","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1161\/HYPERTENSIONAHA.115.06531","volume":"67","author":"C Borghi","year":"2016","unstructured":"Borghi C, Desideri G (2016) Urate-Lowering drugs and prevention of cardiovascular disease: the emerging role of Xanthine oxidase Inhibition. Hypertension 67(3):496\u2013498","journal-title":"Hypertension"},{"issue":"8","key":"3984_CR15","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jamacardio.2019.2202","volume":"4","author":"M Nazarzadeh","year":"2019","unstructured":"Nazarzadeh M, Pinho-Gomes AC, Smith Byrne K et al (2019) Systolic blood pressure and risk of valvular heart disease: A Mendelian randomization Study. JAMA Cardiol 4(8):788\u2013795","journal-title":"JAMA Cardiol"},{"issue":"22","key":"3984_CR16","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1056\/NEJMoa1604304","volume":"375","author":"BA Ference","year":"2016","unstructured":"Ference BA, Robinson JG, Brook RD et al (2016) Variation in PCSK9 and HMGCR and risk of cardiovascular disease and Diabetes. N Engl J Med 375(22):2144\u20132153","journal-title":"N Engl J Med"},{"issue":"5","key":"3984_CR17","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","volume":"36","author":"AR Carter","year":"2021","unstructured":"Carter AR, Sanderson E, Hammerton G et al (2021) Mendelian randomisation for mediation analysis: current methods and challenges for implementation. Eur J Epidemiol 36(5):465\u2013478","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"3984_CR18","doi-asserted-by":"publisher","first-page":"e1006706","DOI":"10.1371\/journal.pgen.1006706","volume":"13","author":"L Folkersen","year":"2017","unstructured":"Folkersen L, Fauman E, Sabater-Lleal M et al (2017) Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease. PLoS Genet 13(4):e1006706","journal-title":"PLoS Genet"},{"issue":"3","key":"3984_CR19","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG (2011) Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol 40(3):755\u2013764","journal-title":"Int J Epidemiol"},{"issue":"11","key":"3984_CR20","doi-asserted-by":"publisher","first-page":"e1009922","DOI":"10.1371\/journal.pgen.1009922","volume":"17","author":"Z Lin","year":"2021","unstructured":"Lin Z, Deng Y, Pan W (2021) Combining the strengths of inverse-variance weighting and Egger regression in Mendelian randomization using a mixture of regressions model. PLoS Genet 17(11):e1009922","journal-title":"PLoS Genet"},{"issue":"4","key":"3984_CR21","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC et al (2016) Consistent Estimation in Mendelian randomization with some invalid instruments using a weighted median Estimator. Genet Epidemiol 40(4):304\u2013314","journal-title":"Genet Epidemiol"},{"issue":"1","key":"3984_CR22","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s40120-021-00310-y","volume":"11","author":"MJ Shu","year":"2022","unstructured":"Shu MJ, Li JR, Zhu YC et al (2022) Migraine and ischemic stroke: A Mendelian randomization Study. Neurol Ther 11(1):237\u2013246","journal-title":"Neurol Ther"},{"issue":"11","key":"3984_CR23","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/nrcardio.2014.123","volume":"11","author":"O Alfieri","year":"2014","unstructured":"Alfieri O, Mayosi BM, Park SJ et al (2014) Exploring unknowns in cardiology. Nat Rev Cardiol 11(11):664\u2013670","journal-title":"Nat Rev Cardiol"},{"key":"3984_CR24","doi-asserted-by":"publisher","first-page":"804159","DOI":"10.3389\/fimmu.2021.804159","volume":"12","author":"DU Pizzagalli","year":"2021","unstructured":"Pizzagalli DU, Pulfer A, Thelen M et al (2021) Vivo motility patterns displayed by immune cells under inflammatory Conditions. Front Immunol 12:804159","journal-title":"Front Immunol"},{"key":"3984_CR25","doi-asserted-by":"publisher","first-page":"956078","DOI":"10.3389\/fimmu.2022.956078","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, Kang Z, Liu Y et al (2022) Identification of immune cell infiltration and diagnostic biomarkers in unstable atherosclerotic plaques by integrated bioinformatics analysis and machine learning. Front Immunol 13:956078","journal-title":"Front Immunol"},{"issue":"27","key":"3984_CR26","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1093\/eurheartj\/ehu203","volume":"35","author":"PM Ridker","year":"2014","unstructured":"Ridker PM, L\u00fcscher TF (2014) Anti-inflammatory therapies for cardiovascular disease. Eur Heart J 35(27):1782\u20131791","journal-title":"Eur Heart J"},{"issue":"1","key":"3984_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-019-0115-y","volume":"5","author":"N Dalbeth","year":"2019","unstructured":"Dalbeth N, Choi HK, Joosten LAB et al (2019) Gout. Nat Rev Dis Primers 5(1):69","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"3984_CR28","first-page":"1722","volume":"36","author":"B Shah","year":"2020","unstructured":"Shah B, Toprover M, Crittenden DB et al (2020) Colchicine use and incident coronary artery disease in male patients with Gout. Can J Cardiol 36(11):1722\u20131728","journal-title":"Can J Cardiol"},{"issue":"19","key":"3984_CR29","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","volume":"383","author":"SM Nidorf","year":"2020","unstructured":"Nidorf SM, Fiolet ATL, Mosterd A et al (2020) Colchicine in patients with chronic coronary Disease. N Engl J Med 383(19):1838\u20131847","journal-title":"N Engl J Med"},{"issue":"7","key":"3984_CR30","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/clc.23830","volume":"45","author":"ME Roth","year":"2022","unstructured":"Roth ME, Chinn ME, Dunn SP et al (2022) Association of Colchicine use for acute gout with clinical outcomes in acute decompensated heart failure. Clin Cardiol 45(7):733\u2013741","journal-title":"Clin Cardiol"},{"issue":"1","key":"3984_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1091\/mbc.e13-06-0294","volume":"25","author":"RE Salinas","year":"2014","unstructured":"Salinas RE, Ogohara C, Thomas MI et al (2014) A cellular genome-wide association study reveals human variation in microtubule stability and a role in inflammatory cell death. Mol Biol Cell 25(1):76\u201386","journal-title":"Mol Biol Cell"},{"key":"3984_CR32","doi-asserted-by":"crossref","unstructured":"Khan S, Andrews KL, Chin-Dusting JPF (2019) Cyclo-Oxygenase (COX) inhibitors and cardiovascular risk: are Non-Steroidal Anti-Inflammatory drugs really Anti-Inflammatory? Int J Mol Sci 20(17):4262","DOI":"10.3390\/ijms20174262"},{"issue":"1","key":"3984_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.rdc.2022.08.006","volume":"49","author":"D Minhas","year":"2023","unstructured":"Minhas D, Nidhaan A, Husni ME (2023) Recommendations for the use of nonsteroidal Anti-inflammatory drugs and cardiovascular disease risk: decades Later, any new lessons Learned?. Rheum Dis Clin North Am 49(1):179\u2013191","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"3984_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jcph.1302","volume":"59","author":"LH Mart\u00edn Arias","year":"2019","unstructured":"Mart\u00edn Arias LH, Mart\u00edn Gonz\u00e1lez A, Sanz Fadrique R et al (2019) Cardiovascular risk of nonsteroidal Anti-inflammatory drugs and classical and selective Cyclooxygenase-2 inhibitors: A Meta-analysis of observational Studies. J Clin Pharmacol 59(1):55\u201373","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"3984_CR35","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1177\/1074248408323136","volume":"13","author":"JJ Warner","year":"2008","unstructured":"Warner JJ, Weideman RA, Kelly KC et al (2008) The risk of acute myocardial infarction with Etodolac is not increased compared to naproxen: a historical cohort analysis of a generic COX-2 selective inhibitor. J Cardiovasc Pharmacol Ther 13(4):252\u2013260","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"4","key":"3984_CR36","doi-asserted-by":"publisher","first-page":"e00817","DOI":"10.1002\/prp2.817","volume":"9","author":"S Dro\u017cd\u017cal","year":"2021","unstructured":"Dro\u017cd\u017cal S, Lechowicz K, Szostak B et al (2021) Kidney damage from nonsteroidal anti-inflammatory drugs-Myth or truth? Review of selected literature. Pharmacol Res Perspect 9(4):e00817","journal-title":"Pharmacol Res Perspect"},{"issue":"9","key":"3984_CR37","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1093\/cvr\/cvab003","volume":"117","author":"L Badimon","year":"2021","unstructured":"Badimon L, Vilahur G, Rocca B et al (2021) The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis. Cardiovasc Res 117(9):2001\u20132015","journal-title":"Cardiovasc Res"},{"issue":"2","key":"3984_CR38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00296-022-05222-0","volume":"43","author":"H Jeong","year":"2023","unstructured":"Jeong H, Choi E, Suh A et al (2023) `Risk of cardiovascular disease associated with febuxostat versus allopurinol use in patients with gout: a retrospective cohort study in Korea. Rheumatol Int 43(2):265\u2013281","journal-title":"Rheumatol Int"},{"key":"3984_CR39","doi-asserted-by":"publisher","first-page":"1759720x2211164","DOI":"10.1177\/1759720X221116409","volume":"14","author":"Y Eun","year":"2022","unstructured":"Eun Y, Han H, Kim K et al (2022) Cardiovascular risk associated with allopurinol or benzbromarone treatment in patients with gout. Ther Adv Musculoskelet Dis 14:1759720x221116409","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"10359","key":"3984_CR40","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/S0140-6736(22)01657-9","volume":"400","author":"IS Mackenzie","year":"2022","unstructured":"Mackenzie IS, Hawkey CJ, Ford I et al (2022) Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial. Lancet 400(10359):1195\u20131205","journal-title":"Lancet"},{"issue":"44","key":"3984_CR41","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1093\/eurheartj\/ehab619","volume":"42","author":"EH Kang","year":"2021","unstructured":"Kang EH, Park EH, Shin A et al (2021) Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout. Eur Heart J 42(44):4578\u20134588","journal-title":"Eur Heart J"},{"issue":"9","key":"3984_CR42","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1136\/heartjnl-2014-306670","volume":"101","author":"FJ de Abajo","year":"2015","unstructured":"de Abajo FJ, Gil MJ, Rodr\u00edguez A et al (2015) Allopurinol use and risk of non-fatal acute myocardial infarction. Heart 101(9):679\u2013685","journal-title":"Heart"},{"issue":"6","key":"3984_CR43","doi-asserted-by":"publisher","first-page":"e99102","DOI":"10.1371\/journal.pone.0099102","volume":"9","author":"VC Kok","year":"2014","unstructured":"Kok VC, Horng JT, Chang WS et al (2014) Allopurinol therapy in gout patients does not associate with beneficial cardiovascular outcomes: a population-based matched-cohort study. PLoS ONE 9(6):e99102","journal-title":"PLoS ONE"},{"issue":"6","key":"3984_CR44","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/ije\/dyx207","volume":"46","author":"VM Walker","year":"2017","unstructured":"Walker VM, Davey Smith G, Davies NM et al (2017) Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities. Int J Epidemiol 46(6):2078\u20132089","journal-title":"Int J Epidemiol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-025-03984-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-025-03984-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-025-03984-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T15:04:24Z","timestamp":1771859064000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-025-03984-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["3984"],"URL":"https:\/\/doi.org\/10.1007\/s00228-025-03984-7","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"Ethical approval was not sought because this study involved the analysis of publicly available summary-level data from GWASs and no individual-level data were used.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}